The Vanderbilt Vaccine Research Program is one of only eight Vaccine Treatment and Evaluation Units (VTEUs) in the U.S. to receive a new contract to continue evaluating innovative vaccines for malaria, pandemic flu, and other infections including TB over the next seven years. The unit may work on phase 1, 2, 3 and 4 clinical trials to evaluate vaccines, therapeutics and diagnostics for safety and effectiveness in a domestic or international setting. VTEUs are on the forefront of research in fighting and preventing infectious diseases.
| Buddy Creech [Email] Pediatric Infectious Disease |
|
| Location |
Nashville, TN |
| Contacts | N/A |
| Program Type |
Research |
| Funding Type |
Grants |
| Region |
North America |
| Global Health Topics |
Infectious Diseases, Neglected Tropical Diseases, Vaccines |
| Eligibility |
|
| Program Length |
Flexible, depending on the individual's interests and needs |
| VU Affiliation |
The program is affiliated with Vanderbilt. |
| Language(s) |
The program does not have a language requirement. |